Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

PDS Biotechnology Q2 EPS $(0.03) Beats $(0.17) Estimate

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.17) by 82.35 percent. This is a 84.21 percent increase over losses of $(0.19) per share from

byBill Haddad

August 12, 2021

1 minute read

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.17) by 82.35 percent. This is a 84.21 percent increase over losses of $(0.19) per share from the same period last year.